Imbalances in the composition and number of bacteria in the gut microbiota have been
implicated in inflammatory bowel disease (IBD), and modulation of the gut microbiota by …

Bacteria play an important role in the pathogenesis of inflammatory bowel disease (IBD), its
complications and its symptoms. Antibiotics can decrease tissue invasion and eliminate …

Inflammatory bowel diseases (IBDs) are chronic diseases of unclear etiology that affect over
1 million individuals in the United States and over 2.5 million people in Europe. However …

Crohn's disease and ulcerative colitis are the two principal forms of inflammatory bowel
disease (IBD). The root causes of these chronic and acute immunological disorders are …

Inflammatory bowel disease (IBD) is a chronic and relapsing inflammatory disorder of the
gut. Although the precise cause of IBD remains unknown, the most accepted hypothesis of …

Inflammatory bowel disease (IBD) is a chronic inflammatory condition of the gastrointestinal
tract encompassing two main clinical entities, Crohn's disease and ulcerative colitis …

The involvement of the gut microbiota in the pathogenesis of IBD is supported by many
findings and is thus now commonly acknowledged. The imbalance in the composition of the …

Patients with inflammatory bowel disease (IBD) exhibit impaired control of the microbiome in
the gut, and 'dysbiosis' is commonly observed. Western diet is a risk factor for the …

Major advances have occurred in the knowledge of the pathogenesis of inflammatory bowel
disease (IBD) over the last decade, and perhaps the most major, and clinically …

Therapeutic strategies for inflammatory bowel disease (IBD) have increased over the past
decade, but considerable unmet needs remain. Increasingly, patients seek safer, long-term …